Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South
University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive
medicine at the University of South China
· Professional training at Huazhong University
of Science and Technology and Tongji
Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Medical expenses of Tulip Hospital in Kyrgyzstan, IVF expenses in Bishkek, ovulation induction drugs, IVF process, night acupuncture expenses, luteal support after transplantation, overseas IVF budget, Kyrgyzstan Reproductive Center.
How to estimate the drug cost of Tulip Hospital in Kyrgyzstan? Understanding the difference between promoting ovulation, night acupuncture and drug use after transplantation in six links
Many people search for the drug cost of Tulip Hospital in Kyrgyzstan? On the surface, I am asking about a price, but in fact I am asking about another more crucial thing: they are all doing test tubes. Why do some people have a low proportion of drug expenses, but some people have opened a clear gap in the drug?
Make the concept clear first. The so-called "drug cost" usually refers not to a single injection of drugs to promote ovulation, but to the sum of several kinds of expenditures related to drugs in a cycle, which usually include ovulation-promoting drugs, antagonists or agonists to inhibit premature ovulation, night acupuncture, luteal support after transplantation, and hormone-adjusting drugs that may be involved in some people. The guidelines of the European Society for Human Reproduction and Embryology (ESHRE) on IVF/ICSI also clearly point out that the management of ovulation promotion itself includes many steps such as gonadotropin stimulation, monitoring, triggering, luteal support and OHSS prevention, so the drug cost is naturally not a single point cost, but a continuous cost tied to the program.
Judging from the Chinese materials published by Tulip Hospital, the hospital's statement of the cost structure is also relatively direct: the complete cycle usually looks not only at the basic package, but also at the medical, pharmaceutical, life and other parts; In the reference structure given by its public page in 2026, the cost of drugs accounts for about 15%-25% of the overall budget, while the overall cost of conventional test tubes is about 25,000-40,000 dollars. Whether to increase PGT and transplant it in stages will continue to affect the total expenditure. Here, it is necessary to directly point out a common misunderstanding: most of the public pages give intervals and proportions, not fixed quotations that are suitable for everyone.
First, from the process point of view: Why is the drug fee "different in the same hospital"
If it is dismantled according to the process, the drug cost mainly appears in three stages.
The first stage is ovulation induction. According to the popular science published by Tulip Hospital, commonly used drugs for promoting ovulation include recombinant FSH, urinary FSH/HMG, and FSH+LH compound preparations, such as Gnafen, Prikang, Lekepregnancy, Minoru, and double fertility. The purity, mode of administration and dosage refinement of different drugs are different, so the price will naturally be different. Especially when doctors need to make individualized initial dose according to AMH, weight and basal follicle number, the difference in drug cost will be more obvious.
The second stage is to prevent premature ovulation and night acupuncture. When the follicle grows to a certain stage, GnRH antagonists or agonists are often added to inhibit LH peak in clinic. The public page lists common drugs such as Si Zekai, Ganarik and Dabijia. Before taking eggs, hCG or GnRH-a will be used as a "night needle" and eggs will be taken strictly according to the time window of 34-36 hours. In other words, the drug fee does not "end when the needle is promoted", but will continue to be superimposed with the results of follicular monitoring.
The third stage is post-transplant support. Many people only focus on the drugs before taking eggs, but ignore the luteal support after transplantation. Tulip Hospital's public page on follow-up and transplant management lists "drug follow-up after transplantation" as a part of continuous management, indicating that the day of transplantation is not the end of drug use. For some patients, the later medication time will be prolonged and the budget will continue to be pushed up.
Second, from a technical point of view: Why do some people have high drug costs and others have low drug costs?
From the first principle, the difference of drug cost comes from two variables: drug intensity and drug use time.
If the ovarian response is weak, it is common in clinic to need a higher dose or a longer number of days to promote ovulation; If you belong to a high reaction group, although you don't necessarily use more drugs, doctors tend to pay more attention to OHSS risk and trigger strategy adjustment. ESHRE's latest guidelines emphasize that promoting ovulation is not the pursuit of "the more drugs, the better", but the balance around ovarian response, safety, compliance and individualization. In other words, the cost of medicine is not simply determined by the hospital, but by age, ovarian reserve, hormone level, past reactions and safety risks.
This differentiated thinking can also be seen in the public case of Tulip Hospital. The example case shows that the patient started to use Gnafen on the third day of menstruation, and adjusted the dose by combining B-ultrasound and hormone results on the fifth day. When the largest follicle reaches 14mm, GnRH antagonist is added to prevent premature ovulation, and finally night acupuncture and egg retrieval are arranged about 10 days after ovulation promotion. This example shows that the drug cost is not written down in advance at one time, but dynamically follows the monitoring results.
Third, who needs to ask more about the "drug cost"
The first category is people over 35 years old or with declining ovarian reserve. This kind of population is more prone to unstable response, limited number of available follicles, and repeated fine-tuning of dosage, and the fluctuation space of drug costs is usually larger. Tulip public content has also repeatedly listed the elderly and people who have failed many times as key consulting groups.
The second group is people with higher AMH, more basal follicles or polycystic tendency. The total cost of this group of people is not necessarily lower, because doctors may pay more attention to the risk control of overstimulation, and the program will pay more attention to monitoring and safety boundaries. ESHRE guidelines include OHSS prevention as the core content, which itself shows that the drug management of high-response people can not only look at cheap or not.
The third category is people who plan to do frozen embryo transplantation or travel in stages. Many people think that the drug fee only occurs in the egg retrieval cycle, but if the subsequent endometrial preparation, corpus luteum support and resuscitation transplantation are carried out separately, the drug fee will be split into different time periods instead of ending at one time. Tulip's public information about follow-up visit and process emphasizes that treatment is often promoted by nodes.
Expert tip: the high cost of medicine does not mean "overcharged"; The low cost of medicine does not mean it is more cost-effective. Whether the judgment is reasonable depends on whether the plan has monitoring basis, whether it explains the logic of adding drugs and reducing drugs, and whether it makes clear the follow-up support drugs.
Fourth, about "the cost of medication in Tulip Hospital in Kyrgyzstan?" High-frequency question and answer
1. Can you directly ask the hospital for a fixed drug cost figure?
You can ask the reference interval, but it is not recommended to regard it as the final budget. Because the public information has shown that Tulip Hospital defines the drug cost as a variable part of the total cost, rather than an absolute constant in the fixed package.
2. Is it more suitable to import drugs to promote excretion?
No. Open science lists different routes such as recombinant FSH, urinary FSH/HMG, FSH+LH compound preparation, etc. Clinical selection usually depends on individual response, dose control, past history and doctor's experience, rather than simply "imported" or "cheap".
3. Do I have to calculate the night needle fee separately?
In most cases, it should be understood separately, because night acupuncture is a key step before taking eggs, and it may not be completely counted in the same category as early drugs to promote ovulation. The public page also explains night acupuncture as an independent medical link.
4. Will you continue to spend money on medicine after transplantation?
Usually. Luteal support and follow-up medication after transplantation are very common in clinic, and tulip public information also includes follow-up medication after transplantation into continuous management.
V. Summary box
Back to the core question, * * What is the drug cost of Tulip Hospital in Kyrgyzstan? * * A more accurate answer is not a unit price, but a judgment logic:
First, look at what kind of people you belong to, then look at what plan to promote ovulation, and then look at how many days it will take, whether to add antagonists, how to give nighttime injections, and how long the support will last after transplantation. The available public information can support the conclusion that the drug cost of Tulip Hospital is usually a variable item in the complete test tube budget, and the public reference accounts for about 15%-25%, but the specific amount is obviously affected by the individual plan.
Common aliases:Kyrgyzstan Tulip Reproductive Center, Tulip IVF, Tulip Reproductive Center, Tulip Hospital, Kyrgyz Tulip Reproductive Center, Kyrgyz Tulip Hospital
